Farther Finance Advisors, LLC

Position in MRNA — Moderna, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in MRNA

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$1,026,718

+$889,826 QoQ

Shares Held

20,211

+335.4% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $14,686,998 across 278 Biotechnology names. MRNA ranks #3 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,752	$2,121,958
2	REGN	Regeneron Pharmaceuticals, Inc.	1,870	$1,444,836
3	MRNA	Moderna, Inc. This page	20,211	$1,026,718
4	SMMT	Summit Therapeutics Inc.	50,316	$953,991
5	HALO	Halozyme Therapeutics, Inc.	13,333	$861,711
6	ARWR	Arrowhead Pharmaceuticals, Inc.	11,971	$750,581
7	EXEL	Exelixis, Inc.	16,443	$705,240
8	BMRN	Biomarin Pharmaceutical Inc	7,857	$443,841

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,026,718	20,211	+335.4%	Shares	Sole	2026-04-07
2025-12-31	$136,892	4,642	+0.7%	Shares	Sole	2026-01-23
2025-09-30	$119,024	4,608	-3.7%	Shares	Sole	2025-10-14
2025-06-30	$131,962	4,783	+34.9%	Shares	Sole	2025-07-11
2025-03-31	$100,500	3,545	+0.7%	Shares	Sole	2025-04-14
2024-12-31	$146,320	3,519	+289.3%	Shares	Sole	2025-02-10
2024-09-30	$60,414	904	-16.5%	Shares	Sole	2024-10-29
2024-06-30	$128,487	1,082	+33.4%	Shares	Sole	2024-07-31
2024-03-31	$86,420	811	+33.4%	Shares	Sole	2024-05-14
2023-12-31	$60,465	608	+147.2%	Shares	Sole	2024-02-15
2023-09-30	$25,409	246	+75.7%	Shares	Sole	2023-11-14
2023-06-30	$17,010	140	+22.8%	Shares	Sole	2024-05-14
2023-03-31	$17,508	114	-26.5%	Shares	Sole	2024-05-14
2022-12-31	$27,841	155	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.